Charles Lee, PhD

Dr. Lee is the scientific director of the Jackson Laboratory for Genomic Medicine and a board certified clinical cytogeneticist with an active research program in the identification and characterization of structural genomic variants using advanced technology platforms. Dr. Lee’s laboratory was the first to describe genome-wide structural genomic variants, in the form of copy number variants (CNVs), among humans with the subsequent development of two human CNV maps that are now actively used in the diagnoses of array-based genetic tests. Since February 2017, Dr. Lee has served as President of the International Human Genome Organization (HUGO International). Dr. Lee previously served as director of the Molecular Genetic Research Unit at Brigham and Women’s Hospital, was an associate professor at Harvard Medical School and was an associate member of the Broad Institute of Harvard & MIT. Dr. Lee received his PhD from the University of Alberta and was a postdoctoral fellow at Cambridge University and Harvard Medical School. Dr. Lee serves on numerous committees and is the founding principal investigator of the Genomic Structural Variation Consortium and co-chair of the structural genomic variation analysis group for the 1000 Genomes Project, an ambitious consortium that is analyzing the genomes of as many as 2,500 individuals from around the world to create the most detailed and medically useful picture, of human genomic variation. (